Published in J Exp Med on June 01, 1976
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A (1990) 4.34
Chemotactic activity of elastin-derived peptides. J Clin Invest (1980) 3.33
Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest (2006) 3.11
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00
The inflammatory response to cell death. Annu Rev Pathol (2008) 2.85
Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol (2010) 2.79
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 1.73
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol (1993) 1.67
Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci U S A (1983) 1.64
N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res (2009) 1.50
Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. J Clin Invest (1976) 1.46
Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest (1985) 1.31
Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest (1979) 1.26
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest (1992) 1.20
Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am J Pathol (1984) 1.19
Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol (1982) 1.18
Degradation of connective tissue components by lung derived leucocytes in vitro: role of proteases and oxidants. Thorax (1988) 1.17
Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal (2008) 1.15
Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle. FASEB J (2011) 1.12
Polymorphonuclear leukocyte and monocyte chemoattractants produced by human fibroblasts. J Clin Invest (1979) 1.10
Collagen as a double-edged sword in tumor progression. Tumour Biol (2013) 1.07
Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest (1981) 0.99
Cellular immunity in glomerulonephritis. Am J Pathol (1982) 0.99
Inflammatory responses in lungs of rats inhaling coalmine dust: enhanced proteolysis of fibronectin by bronchoalveolar leukocytes. Br J Ind Med (1989) 0.99
Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther (2008) 0.99
Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest (1993) 0.99
Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care (2012) 0.98
Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation. J Clin Invest (1990) 0.97
Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation. Open Respir Med J (2010) 0.96
The chemical mediation of delayed hypersensitivity skin reactions. I. Purification of a macrophage-chemotactic factor from bovien gamma-globulin-induced skin reactions in guinea pigs. Am J Pathol (1977) 0.94
Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin. J Clin Invest (1992) 0.92
Is prostaglandin E2 involved in the pathogenesis of fever? Effects of interleukin-1 on the release of prostaglandins. Yale J Biol Med (1986) 0.92
Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis. Ann Rheum Dis (1982) 0.91
Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Pathol (1987) 0.91
Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect Immun (2009) 0.89
Monocyte chemoattractants in pigeon aortic atherosclerosis. Am J Pathol (1987) 0.87
Interfering with extracellular matrix degradation to blunt inflammation. Curr Opin Pharmacol (2008) 0.87
The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability. Sci Adv (2015) 0.86
The chemical mediation of delayed hypersensitivity skin reaction. II. Characterization of a macrophage-chemotactic factor from bovine gamma-globulin-induced skin reaction in guinea pigs. Am J Pathol (1978) 0.84
Thyroid capsule changes during the development of thyroid hyperplasia in the rat. Am J Pathol (1978) 0.83
Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation. Mediators Inflamm (1994) 0.82
Control of cellular influx in lung and its role in pulmonary toxicology. Environ Health Perspect (1984) 0.82
Studies on mRNA expression of tissue-type plasminogen activator in bruises for wound age estimation. Int J Legal Med (2004) 0.81
Extracellular hydrolytic enzymes of rabbit dermal tuberculous lesions and tuberculin reactions collected in skin chambers. Am J Pathol (1978) 0.81
Collagen inhibitory peptide R1R2 mediates vascular remodeling by decreasing inflammation and smooth muscle cell activation. PLoS One (2015) 0.81
Bioactive extracellular matrix fragments in lung health and disease. J Clin Invest (2016) 0.80
Secretion of chondrocyte stimulating factor by macrophages as a result of activation with collagen and proteoglycans. Clin Exp Immunol (1983) 0.79
Persistent biological reactivity of quartz in the lung: raised protease burden compared with a non-pathogenic mineral dust and microbial particles. Br J Ind Med (1991) 0.79
Effects of elastin-derived peptide on Achilles' tendon healing: an experimental study. J Mater Sci Mater Med (2003) 0.78
Development of a silk and collagen fiber scaffold for anterior cruciate ligament reconstruction. J Mater Sci Mater Med (2012) 0.76
Collagen-derived peptides release mast cell histamine. Agents Actions (1986) 0.75
TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Arterioscler Thromb Vasc Biol (2017) 0.75
Receptor mediated endocytosis by mesangial cells modulates transmigration of macrophages. Inflammation (2000) 0.75
N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Leukotactic factor produced by sensitized lymphocytes. Science (1969) 3.95
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol (1970) 3.17
Chemotoxis of mononuclear cells. J Exp Med (1968) 2.95
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
Some properties of the products of reaction of tadpole collagenase with collagen. Biochemistry (1967) 2.56
A chemotactic factor for mononuclear leukocytes. Proc Soc Exp Biol Med (1971) 2.18
Collagenases (first of three parts). N Engl J Med (1974) 2.06
Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry (1969) 1.63
Characterization of the cyanogen bromide peptides from the alpha 1 chain of chick skin collagen. Biochemistry (1969) 1.63
Characterization of the cyanogen bromide peptides from the alpha-2 chain of chick skin collagen. Biochemistry (1969) 1.46
Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages. Immunology (1973) 1.42
Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin. J Immunol (1974) 1.22
Demonstration of the chemotactic properties of collagen. Proc Soc Exp Biol Med (1970) 1.14
Characterization of chemotactic activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1975) 1.13
The chemotaxis of selected cell types to connective tissue degradation products. Ann N Y Acad Sci (1975) 1.04
Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med (1971) 1.03
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci U S A (1978) 3.00
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest (1976) 2.60
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28
Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine. Biochemistry (1972) 2.25
Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20
Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules. J Immunol (1984) 2.18
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Isolation of two distinct collagens from chick cartilage. Biochemistry (1970) 2.14
Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem (1980) 2.13
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med (1981) 2.10
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem (1988) 1.93
An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med (1997) 1.89
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest (1977) 1.68
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Characterization of the alpha-chains of chick skin collagen and the nature of the NH2-terminal cross-link region. Biochemistry (1969) 1.63
Characterization of the cyanogen bromide peptides from the alpha 1 chain of chick skin collagen. Biochemistry (1969) 1.63
Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest (1989) 1.62
Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane. J Biol Chem (1982) 1.62
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum (1990) 1.61
The nature and location of intramolecular cross-links in collagen. Proc Natl Acad Sci U S A (1966) 1.60
Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59
Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry (1966) 1.59
Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med (1976) 1.57
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry (1967) 1.54
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51
Collagen heterogeneity. High resolution separation of native ( 1(I) 2 2 and ( 1(II) 3 and their component chains. J Biol Chem (1972) 1.50
Specific cleavage of human type III collagen by human polymorphonuclear leukocyte elastase. J Biol Chem (1980) 1.50
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Identification of specific sites in the TNF-alpha molecule promoting insulin resistance in H-411E cells. J Lab Clin Med (1997) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Characterization of the cyanogen bromide peptides from the alpha-2 chain of chick skin collagen. Biochemistry (1969) 1.46
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest (1987) 1.43
The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum (1990) 1.40
Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med (1989) 1.39
Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum (1984) 1.36
The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum (2000) 1.34
Secreted forms of human neutrophil collagenase. J Biol Chem (1986) 1.31
Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest (1985) 1.30
Animal collagenases: specificity of action, and structures of the substrate cleavage site. Biochem Biophys Res Commun (1974) 1.27
Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol (1998) 1.27
The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med (Berl) (1998) 1.26
Generation of a fibroblast chemotactic factor in serum by activation of complement. J Clin Invest (1979) 1.26
Collagen heterogeneity within different growth regions of long bones of rachitic and non-rachitic chicks. Biochem J (1972) 1.26
Transcriptional regulation of type I collagen genes in cultured fibroblasts by a factor isolated from thioacetamide-induced fibrotic rat liver. J Biol Chem (1984) 1.23
Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor. J Immunol (1976) 1.23
Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures. J Exp Med (1983) 1.22
Ectoprotein kinase activity of the isolated rat adipocyte. Biochem Biophys Res Commun (1979) 1.22
Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages. Biochem Biophys Res Commun (1980) 1.21
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
A collagen defect in homocystinuria. J Clin Invest (1973) 1.20
Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver. Biochemistry (1981) 1.17
A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J Immunol (1989) 1.16
Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts. J Biol Chem (1986) 1.16
T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol (1993) 1.16
Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16
The in vitro formation of intermolecular cross-links in chick skin collagen. Biochem Biophys Res Commun (1970) 1.16
Type-specific collagen degradation by eosinophils. Biochem J (1982) 1.15
Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J Immunol (1994) 1.15
Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med (1988) 1.12
Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12
Collagen autoimmunity and arthritis. FASEB J (1988) 1.11
Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J Clin Invest (1989) 1.11
Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem (1986) 1.10
Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am J Physiol (1992) 1.10